Sunesis Pharmaceuticals Reports First Quarter 2012 Financial Results and Highlights – msnbc.com

For more information on the VALOR trial, please visit www.valortrial.com . About Vosaroxin Vosaroxin is a first-in-class anti-cancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer.